Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Family Medicine Physician in Chula Vista, CA
NPI: 1649353095Primary Practice Location
SHARP CHULA VISTA MEDICAL CENTER
751 Medical Center Ct, Chula Vista, CA
Primary Employer
Peak Health Group
peakhealthgroup.com
HQ Phone
Get M.D. Patrick's Phone Numberphone_androidMobile
Get M.D. Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1997 - 2026
American Board of Family Medicine
Family Medicine
University of California (San Diego) Medical Center
Residency • Family Medicine
1997 - 2000
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Surgery
1995 - 1997
West Virginia University School Of Medicine
medicine.wvu.edu
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 21 | 32 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 19 | 43 |
| 3 | 36410Insertion of needle into vein, patient 3 years or older | 17 | 19 |
| 4 | 99211Established patient office or other outpatient visit, typically 5 minutes | 12 | 16 |
Glioma-stimulated chemoattraction of endothelial cells and fibroblastsin vitro: a model for the study of glioma-induced angiogenesis
Authors: Patrick R. Yassini, D. L. Stickler, S. M. Bloomfield, Richard C. Wiggins, Gregory W. Konat
Authors: Stephen Bloomfield
Journal: J Neurosurg
Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults.
Authors: Patrick Yassini, Mark Hutchens, Yamuna D Paila, Lorraine Schoch, Anne Aunins
Lead Sponsor: Biomedical Advanced Research and Development Authority
Intervention / Treatment: BIOLOGICAL: MF59 adjuvant, BIOLOGICAL: AS03 adjuvant, BIOLOGICAL: VN, BIOLOGICAL: IN, BIOLOGICAL: dk/BANG, BIOLOGICAL: gf/WA, BIOLOGICAL: bhg/QL
